Jamie L Wooldridge
Overview
Explore the profile of Jamie L Wooldridge including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
118
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wooldridge J, Mason S, Brusatti J, Albers G, Noyes B
Pediatrics
. 2015 Nov;
136(6):e1611-6.
PMID: 26574591
Background: The Cystic Fibrosis (CF) Foundation recommends patients attend clinic ≥4 times per year with 4 respiratory cultures and 2 pulmonary function tests (PFTs). However, nationally only 57.4% of patients...
2.
Powers S, Stark L, Chamberlin L, Filigno S, Sullivan S, Lemanek K, et al.
JAMA Pediatr
. 2015 May;
169(5):e150636.
PMID: 25938655
Importance: Evidence-based treatments that achieve optimal energy intake and improve growth in preschool-aged children with cystic fibrosis (CF) are a critical need. Objective: To test whether behavioral and nutritional treatment...
3.
Wooldridge J, Szczesniak R, Fenchel M, Elder D
J Cyst Fibros
. 2015 Mar;
14(6):792-7.
PMID: 25754095
Background: The aim of this study is to assess insulin secretion in pediatric cystic fibrosis (CF) patients with exocrine pancreatic sufficiency. Methods: Glucose and insulin responses during an oral glucose...
4.
Wooldridge J, Schaeffer D, Jacobs D, Thieroff-Ekerdt R
J Pediatr Gastroenterol Nutr
. 2014 Jul;
59(5):612-5.
PMID: 25050848
The objective of our study was to determine whether infants with cystic fibrosis who developed exocrine pancreatic insufficiency in early infancy would tolerate long-term treatment with ZENPEP (pancrelipase) delayed-release capsules,...
5.
Grossoehme D, Ragsdale J, Cotton S, Wooldridge J, Grimes L, Seid M
J Health Care Chaplain
. 2010 Jul;
16(3-4):109-22.
PMID: 20658425
Parents of children diagnosed with cystic fibrosis described it as "devastating." Given religion's importance to many Americans, parents may utilize religious coping. Relatively little is known about parents' use of...
6.
Grossoehme D, Ragsdale J, Wooldridge J, Cotton S, Seid M
J Health Care Chaplain
. 2010 Jul;
16(3-4):95-108.
PMID: 20658424
The diagnosis of a child's life-shortening disease leads many American parents to utilize religious beliefs. Models relating religious constructs to health have been proposed. Still lacking are inductive models based...
7.
Wooldridge J, Heubi J, Amaro-Galvez R, Boas S, Blake K, Nasr S, et al.
J Cyst Fibros
. 2009 Aug;
8(6):405-17.
PMID: 19683970
Background: EUR-1008 (Zenpep [pancrelipase]) is a new, enteric-coated, porcine-derived pancreatic enzyme product (PEP) developed for the treatment of cystic fibrosis (CF) patients with malabsorption associated with exocrine pancreatic insufficiency (EPI)....
8.
Ernst M, Wooldridge J, Conway E, Dressman K, Weiland J, Tucker K, et al.
J Pediatr Psychol
. 2009 Apr;
35(1):14-24.
PMID: 19366791
Objective: The objective of this study was to use quality improvement science methodology to develop a multidisciplinary intervention improving occurrence of best-practice airway clearance therapy (ACT) in inpatient adolescents with...
9.
Elder D, Wooldridge J, Dolan L, DAlessio D
J Pediatr
. 2007 Nov;
151(6):653-8.
PMID: 18035147
Objective: To determine the prevalence of abnormalities of glucose metabolism in pediatric outpatients with cystic fibrosis (CF). Study Design: Children and adolescents (n = 73, mean age 15.0 +/- 3.7...
10.
Wooldridge J, Deutsch G, Sontag M, Osberg I, Chase D, Silkoff P, et al.
Pediatr Pulmonol
. 2004 Mar;
37(4):338-50.
PMID: 15022131
Controversy exists concerning abnormalities of the nitric oxide (NO) pathway in cystic fibrosis (CF) lung disease. Although some studies suggested that NO activity is impaired in CF, changes in NO...